NYSE · Financial Statements

Shoulder Innovations, Inc. (SI) Revenue, Earnings & Financial Statements

$20.64 NYSE: SI Market Cap $431.83M

Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Shoulder Innovations, Inc. most recently reported annual revenue of $47.0M, a net loss of $40.0M. Revenue grew at an average annual rate of 57.3% over the last 2 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Shoulder Innovations, Inc.: Revenue rose from $19.0M in 2023 to $47.0M in 2025, a change of +147.4% over 2 years; net profit was positive in 0 of 3 reported years; operating margin moved from -56.4% to -55.6%, a shift of +0.8 percentage points; the most recent year shows a net loss of $40.0M.

Income Statement — 3 Years (USD millions)

Metric202320242025
Revenue$19.0M$32.0M$47.0M
Operating Expenses$30.0M$46.0M$74.0M
Operating Profit−$11.0M−$15.0M−$26.0M
Operating Margin-56.4%-46.3%-55.6%
Other Income−$2.0M−$1.0M−$14.0M
Interest$1.0M$1.0M$0
Depreciation$2.0M$2.0M$3.0M
Profit Before Tax−$13.0M−$16.0M−$40.0M
Tax rate (%)0.0%0.0%0.0%
Net Profit−$13.0M−$16.0M−$40.0M
EPS−$0.63−$0.77−$1.96

Quarterly Results — Last 12 Quarters (USD millions)

3 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$7.0M$7.0M$8.0M$7.0M$9.0M$10.0M$11.0M$12.0M$14.0M$17.0M$17.0M$16.0M
Operating Expenses$9.0M$10.0M$12.0M$11.0M$12.0M$14.0M$17.0M$19.0M$23.0M$26.0M$27.0M$24.0M
Operating Profit−$2.0M−$3.0M−$4.0M−$4.0M−$4.0M−$4.0M−$6.0M−$8.0M−$8.0M−$9.0M−$10.0M−$8.0M
Operating Margin-35.2%-45.3%-48.2%-52.1%-40.5%-42.4%-53.2%-65.0%-59.0%-53.7%-58.4%-46.9%
Interest$1.0M$0$0$0$0$0$0$0$1.0M$0$0$1.0M
Profit Before Tax−$3.0M−$4.0M−$4.0M−$4.0M−$4.0M−$5.0M−$19.0M−$9.0M−$8.0M−$8.0M−$10.0M−$7.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$3.0M−$4.0M−$4.0M−$4.0M−$4.0M−$5.0M−$19.0M−$9.0M−$8.0M−$8.0M−$10.0M−$7.0M
EPS−$0.13−$0.18−$0.21−$0.20−$0.19−$0.23−$0.95−$0.43−$0.38−$0.41−$0.49−$0.34

Over the 3 years reported for Shoulder Innovations, Inc., borrowings increased from $14.0M in 2023 to $15.0M in 2025, cash stood at $27.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 11.21 times.

Balance Sheet — 3 Years (USD millions)

Metric202320242025
Total Assets$54.0M$43.0M$170.0M
Current Assets$48.0M$35.0M$157.0M
Cash$6.0M$6.0M$27.0M
Inventory$10.0M$14.0M$22.0M
Receivables$5.0M$5.0M$8.0M
Fixed Assets$6.0M$8.0M$13.0M
Capital Work in Progress$0$0$0
Investments$27.0M$9.0M$97.0M
Other Assets$0$0$0
Total Liabilities$94.0M$98.0M$29.0M
Current Liabilities$4.0M$8.0M$14.0M
Borrowings$14.0M$15.0M$15.0M
Other Liabilities$80.0M$83.0M$14.0M
Equity$0$0$0
Reserves−$40.0M−$55.0M$141.0M

For Shoulder Innovations, Inc., operating cash flow was positive in 0 of 3 reported years; free cash flow in the latest year was negative at $36.0M; free cash flow was positive in 0 of 3 years.

Cash Flow Statement — 3 Years (USD millions)

Metric202320242025
Operating Cash Flow−$13.0M−$14.0M−$29.0M
Investing Cash Flow−$32.0M$10.0M−$103.0M
Financing Cash Flow$0$0$0
Net Cash Flow$3.0M$0$21.0M
Free Cash Flow−$16.0M−$18.0M−$36.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.71
EV / EBITDA-12.34
FCF Yield-11.68%
Quick Ratio8.92
Interest Coverage37.04
Return 1Y40.75%
Return 3Y—
Return 5Y—

Shoulder Innovations, Inc. (SI) financials — frequently asked questions

What is Shoulder Innovations, Inc.'s annual revenue?

Shoulder Innovations, Inc. (SI) reported annual revenue of $47.0M in its most recent fiscal year.

What is Shoulder Innovations, Inc.'s net profit?

Shoulder Innovations, Inc. (SI) reported a net loss of $40.0M in its most recent fiscal year.

What is SI EV/EBITDA?

Shoulder Innovations, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -12.34. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Medical - Specialties stocks

ALC revenue $10.4BSTE revenue $5.9BMLAB revenue $249.0MQDEL revenue $2.7BMOBI stockMASS revenue $56.0MANIK revenue $113.0MAPYX revenue $53.0MSKIN revenue $301.0MNYXH revenue $10.0MAll Healthcare stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
SI Overview SI Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.